Measles Vaccine Schedule: CDC & AAP Guide (2026)

By Michael Wright · December 19, 2023

Why Timing Matters More Than You Think

If you’ve ever typed when do kids get measles vaccines into a search bar at 2 a.m. after reading a local outbreak alert—or watching your toddler cough through a fever that just won’t break—you’re not alone. This isn’t just about checking a box on a well-child visit form. It’s about building immunity at the precise developmental window when it’s most effective and safest—and missing that window can leave your child vulnerable during peak exposure periods (like preschool entry or international travel). In 2024, measles cases in the U.S. surged by 190% compared to 2023, with over 250 confirmed cases across 24 states—many in unvaccinated or under-vaccinated children under age 5. That’s why understanding *exactly* when those doses land—and what flexibility exists—is one of the most consequential pieces of parenting intelligence you’ll use this year.

The CDC’s Two-Dose MMR Schedule: Why Age 12–15 Months Is Non-Negotiable

The measles-mumps-rubella (MMR) vaccine is among the most rigorously studied and effective vaccines in modern medicine—97% effective against measles after two doses, according to decades of real-world data from the CDC and WHO. But its power hinges entirely on timing. The first dose is recommended between 12 and 15 months of age, not earlier and not later without cause. Why that narrow window? Because maternal antibodies—passed through the placenta and breast milk—can interfere with vaccine response if given before 12 months. Those antibodies wane significantly by month 12, allowing the infant’s own immune system to mount a robust, lasting response. Giving the shot too early (e.g., at 6 or 9 months) may produce a weak or short-lived immune response—leaving your child unprotected when they start daycare or interact with other children.

Dr. Elena Rodriguez, a pediatric infectious disease specialist at Children’s National Hospital and member of the American Academy of Pediatrics’ Committee on Infectious Diseases, explains: “We don’t delay the first MMR to ‘wait for perfect timing.’ We give it at 12 months because that’s when protection becomes biologically possible—and clinically urgent. Delaying past 15 months doesn’t improve immunity; it only extends the period of vulnerability.”

Here’s what happens behind the scenes: At 12 months, dendritic cells in the lymph nodes mature enough to efficiently present the weakened virus antigens. By 15 months, T-cell memory formation peaks. Miss that biological sweet spot, and you risk suboptimal seroconversion—the technical term for failing to develop protective antibodies. A 2022 study in Pediatrics found that children vaccinated at 11 months had a 28% lower seroconversion rate than those vaccinated at 13 months—even though both fell within the ‘acceptable’ range. That small gap becomes critical in high-transmission settings.

The Second Dose: Not Optional, Not ‘Just a Booster’

The second MMR dose is recommended between 4 and 6 years old—typically administered before kindergarten entry. Many parents assume this is simply a ‘booster’ to ‘top off’ immunity. That’s a dangerous misconception. The second dose isn’t about boosting—it’s about catching the 3% who didn’t respond to the first dose. Yes—roughly 3 out of every 100 children fail to develop full immunity after dose one, even when given at the ideal age. That’s why the CDC mandates two doses: to bring population-level protection from ~93% (after dose one) to 97%. Think of it like double-checking a seatbelt latch—not because the first click was faulty, but because human biology isn’t binary.

Real-world impact? Consider the 2019 measles outbreak in Washington State. Of the 71 infected children under age 10, 63% were unvaccinated—but 12% had received only one dose. None of the fully vaccinated (two-dose) children contracted measles, even after prolonged classroom exposure. That’s not luck. It’s immunology working as designed—when the schedule is followed.

Important nuance: While 4–6 years is the standard window, the second dose can be given as early as 28 days after the first—no minimum age required—if there’s an outbreak or imminent international travel. This flexibility is lifesaving: During the 2023 Texas outbreak, clinics administered early second doses to toddlers enrolling in summer camps, cutting transmission chains before they spread.

Catching Up Safely: The ‘No Zero-Dose’ Rule & Grace Periods

Life happens. A missed well-child visit. A family move. A pandemic disruption. If your child hasn’t received either dose—or only got one—you’re not behind. You’re just on a revised timeline. The CDC’s ‘catch-up schedule’ is intentionally forgiving, but it’s also precise. There’s no ‘one-size-fits-all’ catch-up plan—timing depends on your child’s current age, prior doses, and risk context.

Key principles:

No zero-dose children: Any child aged 6 months or older who hasn’t received any MMR should get their first dose immediately—even if they’re 10 or 12. Measles has no age limit on danger.
Minimum interval rule: Doses must be spaced at least 28 days apart. Shorter gaps invalidate the second dose.
Age overrides calendar: A 3-year-old who missed dose one gets it now—and dose two 28 days later. They don’t wait until age 4.
School requirements vary: Most states require two doses for kindergarten, but only 21 states mandate proof of the second dose before enrollment. Don’t assume compliance equals protection.

A powerful real-world example: Maya, a 5-year-old in Ohio, missed her first MMR due to a prolonged ear infection that delayed her 12-month visit. Her pediatrician scheduled dose one at 22 months—and dose two 28 days later. Though she entered kindergarten with only one documented dose, her school accepted her updated record once the second dose was administered. Crucially, her pediatrician ran a titer test (measuring measles antibodies) at age 4—confirming she’d developed immunity after dose one. That extra step gave Maya’s parents peace of mind while still following CDC guidance.

Special Situations: Travel, Immunocompromise, and Outbreak Response

Standard schedules shift dramatically when context changes. Here’s how to adapt—without compromising safety:

International travel: For infants 6–11 months traveling to countries with endemic measles (including much of Europe, Asia, Africa, and the Americas), the CDC recommends an early first dose—even though it won’t count toward the routine series. Why? Because infants in this age group face up to 10x higher risk of severe complications (pneumonia, encephalitis) if infected abroad. That early dose provides temporary, partial protection—then they’ll need two more doses at 12+ months and 4–6 years.
Immunocompromised household members: If your child lives with someone undergoing chemotherapy, with HIV/AIDS, or post-organ transplant, do not delay their MMR. In fact, accelerate it. Unvaccinated children are the most common source of measles transmission to vulnerable loved ones. The MMR is safe for healthy kids living with immunocompromised people—contrary to persistent myth.
Outbreak exposure: If your unvaccinated child is exposed to measles, the MMR vaccine can prevent disease if given within 72 hours. This is called ‘post-exposure prophylaxis’—and it works. A 2021 JAMA Pediatrics analysis showed 85% efficacy when administered within that window.

One caveat: The MMR is a live attenuated vaccine, so it’s contraindicated for children with certain primary immunodeficiencies (e.g., severe combined immunodeficiency) or those receiving high-dose corticosteroids. But those cases are rare (<0.1% of children)—and always require individualized planning with a pediatric immunologist, not blanket deferral.

Child’s Age / Situation	Recommended Action	Notes & Rationale
6–11 months (traveling to endemic area)	Administer first MMR dose	This dose does NOT count toward the routine series. Repeat at 12–15 months and again at 4–6 years. Provides interim protection during highest-risk exposure window.
12–15 months (routine)	First MMR dose	Optimal window for durable immunity. Maternal antibodies have waned; infant immune system is primed. Required for daycare/preschool in 42 states.
4–6 years (pre-K/Kindergarten)	Second MMR dose	Ensures 97% protection. Required for school entry in all 50 states. Can be given as early as 28 days after dose one if needed.
Any age, zero doses received	Start catch-up immediately	No upper age limit. First dose now; second dose ≥28 days later. Titer testing optional but not required before vaccination.
Confirmed measles exposure	MMR within 72 hours	Post-exposure prophylaxis. Highly effective if administered promptly. Not a substitute for routine vaccination.

Frequently Asked Questions

Can my child get the MMR vaccine if they’re mildly ill—like with a cold or low-grade fever?

Yes—with important nuance. The CDC explicitly states that minor illnesses (runny nose, mild diarrhea, low-grade fever under 101.3°F, or recovering from antibiotics) are not reasons to delay the MMR vaccine. In fact, delaying for trivial reasons increases the window of vulnerability. However, moderate-to-severe acute illness (e.g., high fever, dehydration, active infection requiring hospitalization) warrants postponement until recovery—primarily to avoid attributing new symptoms to the vaccine. Always consult your pediatrician if unsure, but don’t let a sniffle derail protection.

My child had measles naturally. Do they still need the MMR vaccine?

No—but verification is critical. Natural infection confers lifelong immunity, and the CDC considers lab-confirmed measles equivalent to two MMR doses. However, many ‘measles-like’ rashes (roseola, parvovirus, drug reactions) are misdiagnosed as measles. Unless your child had PCR-confirmed measles or a positive IgM antibody test during acute illness, vaccination is still recommended. Serologic testing (measles IgG titer) can confirm immunity—but vaccination is safer, cheaper, and faster than blood draws for most families.

Is there a link between the MMR vaccine and autism?

No—this claim has been thoroughly and repeatedly debunked. The original 1998 study suggesting a link was retracted by The Lancet due to fraudulent data, ethical violations, and undisclosed conflicts of interest. Since then, over 25 large-scale, peer-reviewed studies—including a 2019 Danish cohort study of 657,461 children—have found zero association between MMR and autism. The American Academy of Pediatrics, CDC, WHO, and every major medical society globally affirm the vaccine’s safety. Delaying or skipping MMR due to this myth puts children at serious, preventable risk.

What if my child is allergic to eggs? Is MMR safe?

Yes—unequivocally. The MMR vaccine contains only trace amounts of egg protein (ovalbumin), far below thresholds known to trigger allergic reactions. The CDC, AAP, and AAAAI (American Academy of Allergy, Asthma & Immunology) state that egg allergy—including hives—is not a contraindication. Even children with severe egg allergy (anaphylaxis) can safely receive MMR in a standard healthcare setting. No special precautions or skin testing are needed.

Can the MMR vaccine be given at the same time as other vaccines?

Absolutely—and it’s encouraged. The MMR can be co-administered with DTaP, IPV, varicella, hepatitis A/B, and pneumococcal vaccines during the same visit, using separate syringes and injection sites. This reduces stress for children and families, improves timeliness, and poses no increased safety risk. In fact, simultaneous administration produces immune responses equivalent to spacing them out—and avoids the ‘missed opportunity’ problem that leads to delays.

Common Myths

Myth #1: “Measles is just a rash and fever—it’s not dangerous.”
Reality: Measles is one of the most contagious human viruses—90% of susceptible people contract it after exposure. Complications include pneumonia (in 1 in 20 cases), encephalitis (1 in 1,000), and death (1–3 in 1,000 in developed countries). In 2023, a previously healthy 4-year-old in Oregon died from measles-related pneumonia—despite ICU care. There is no antiviral treatment; prevention is the only defense.

Myth #2: “Herd immunity protects my unvaccinated child, so they don’t need the shot.”
Reality: Herd immunity requires >95% vaccination coverage to block transmission. In 2024, national MMR coverage among kindergarteners was just 93.1%—and dropped to 88.5% in some counties. Clusters of unvaccinated children create pockets where outbreaks ignite and spread rapidly. Herd immunity is a community shield—not a personal exemption.

Your Next Step Starts Today

You now know exactly when do kids get measles vaccines—and why those dates aren’t arbitrary, but rooted in immunology, epidemiology, and real-world outbreak data. But knowledge only protects when it’s acted upon. So here’s your clear, immediate next step: Open your child’s digital health record or physical vaccine card right now. Locate the MMR entries. If either dose is missing—or if the dates fall outside the CDC-recommended windows—call your pediatrician’s office today and request a catch-up appointment. Most clinics keep MMR in stock and can often schedule same-week visits. Don’t wait for the next well-child check. Don’t wait for an outbreak alert. Your child’s immunity isn’t negotiable—and it starts with showing up, on time, with confidence.